Ignite Creation Date:
2025-12-26 @ 10:44 PM
Ignite Modification Date:
2026-01-01 @ 6:37 PM
Study NCT ID:
NCT06903312
Status:
RECRUITING
Last Update Posted:
2025-07-03
First Post:
2025-03-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.
Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-15
Start Date Type:
ACTUAL
Primary Completion Date:
2027-10-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-03-24
First Submit QC Date:
None
Study First Post Date:
2025-03-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-30
Last Update Post Date:
2025-07-03
Last Update Post Date Type:
ACTUAL